Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Director | Anderson Robert Eugene Jr | Nov 24, 2025 | Buy | $24.94K | 8,600 |
| CEO | Barry Richard | Nov 20, 2025 | Buy | $414K | 150,000 |
| CEO | Barry Richard | Nov 19, 2025 | Buy | $201.81K | 73,385 |
| Chief Operating & Legal Office | Cook Robert Christopher | Sep 30, 2025 | Buy | $39.94K | 13,725 |
| CEO | Barry Richard | Sep 22, 2025 | Buy | $16.35K | 7,172 |
| CEO | Barry Richard | Sep 19, 2025 | Buy | $900 | 400 |
| CEO | Barry Richard | Sep 19, 2025 | Buy | $107.42K | 46,908 |
| CEO | Barry Richard | Sep 18, 2025 | Buy | $11.5K | 5,400 |
| CEO | Barry Richard | Sep 18, 2025 | Buy | $414.92K | 185,233 |
| Chief Medical Officer | Kupiec James William | Nov 29, 2024 | Sell | $15.48K | 4,000 |
| CFO | Schoen Eric | Nov 29, 2024 | Sell | $7.64K | 2,000 |
| CFO | Schoen Eric | Nov 29, 2024 | Sell | $230.83K | 59,800 |
| Director | ROBERTSON SANFORD | Aug 23, 2023 | Buy | $523.5K | 30,000 |
| Director | Barry Richard | Aug 22, 2023 | Buy | $275.91K | 16,571 |
| Director | Barry Richard | Aug 21, 2023 | Buy | $32.02K | 1,906 |
| Director | Barry Richard | Mar 7, 2023 | Buy | $1.99M | 77,276 |
| Director | Barry Richard | Mar 6, 2023 | Buy | $302.19K | 11,565 |
| Director | Barry Richard | Aug 23, 2022 | Buy | $860.22K | 36,159 |
| Chief Clinical Dev. Officer | Kupiec James William | Aug 23, 2022 | Buy | $61.1K | 2,500 |
| Director | ROBERTSON SANFORD | Aug 12, 2022 | Buy | $2.07M | 100,000 |
| CFO | Schoen Eric | Aug 12, 2022 | Buy | $49.88K | 2,500 |
| CEO | BARBIER REMI | Sep 24, 2020 | Buy | $95.9K | 10,000 |
| Director | ROBERTSON SANFORD | Sep 18, 2020 | Buy | $323.63K | 36,281 |
| CFO | Schoen Eric | Sep 17, 2020 | Buy | $70.3K | 10,000 |
| Director | ROBERTSON SANFORD | Sep 17, 2020 | Buy | $1.49M | 213,719 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.